These results are consistent with the results of human bladder cancer tissues, further suggesting that high GOLPH3 expression may contribute to the proliferation of bladder cancer and indicating that GOLPH3 may be a good therapeutic target for halting the proliferation and tumorigenesis of bladder cancer. This evidence concerns the gene GOLPH3 and urinary bladder cancer.